Stay up to date

We recently held our first EDCTP Fellow's Day linked to the 9th EDCTP Forum in Lisbon, Portugal. We welcomed over 70 Fellows from around sub-Saharan Africa to discuss issues around good mentorship and research leadership in Africa. We heard from Professor Akuffo on the roles of supervisors and mentors in brining up the next generation of research leaders in Africa. We also heard from some of our Fellows on their personal journey to leadership and were very encouraged to hear just how much has been acomplished!

Dr Isidore Traore, a Medical Doctor, with a Master degree in biostatistics and a PhD in epidemiology who joined the Global Clinical Operations (GCO) organization at Merck for 15 months to enhance his skills in the area of clinical practices and operations. Highly motivated, Isidore arrived at Merck from Burkina Faso, specifically from the Centre Muraz in Bobo-Dioulasso where he has been working with increasing responsibilities as of 2001.

And now one year later, back in his country, he is implementing all the learnings and advanced knowledge through a series of activities. Isidore Traore who confirmed, ”At Merck I have learnt to be more self-confident and to work efficiently. I am now sharing these skills with my colleagues in Burkina Faso.”

The fellowship also allowed Isidore to step up his carrier, obtaining the position of Assistant Professor at the University of Bobo-Dioulasso.             Congratulations Isidore!

https://www.merckglobalhealthinstitute.com/en/home.html

Nominations for the African Union Kwame Nkrumah Awards for Scientific Excellence are now open!

Please visit https://au.int/en/announcements/20180611/african-union-kwame-nkrumah-awards-scientific-excellence-auknase-continental for the Rules of Procedure and Nomination forms in English and in French.

The deadline for submission of applications is 10th of November 2018 at 17:00 hours Addis Ababa time.

Although significant progress has been made, the latest data from low- and middle-income countries show substantial gaps in reaching the third “90%” (viral suppression) of the UNAIDS 90-90-90 goals, especially among vulnerable and key populations. This article discusses critical gaps and promising, evidence-based solutions. There is no simple and/or single approach to achieve the last 90%. This will require multifaceted, scalable strategies that engage people living with human immunodeficiency virus, motivate long-term treatment adherence, and are community-entrenched and ‑supported, cost-effective, and tailored to a wide range of global communities.